Advanced search×

Positron emission tomography for benign and malignant disease.

Anthony A Visioni and Julian J Kim

Surg Clin North Am 91(1):249-66 (2011) PMID 21184913

Functional imaging using radiolabeled probes that specifically bind and accumulate in target tissues has improved the sensitivity and specificity of conventional imaging. Fluorodeoxyglucose (FDG)-positron emission tomography (PET) has shown improved diagnostic accuracy in differentiating benign from malignant lesions in the setting of solitary pulmonary nodules. FDG-PET has become useful in preoperative staging of patients with lung cancer, and is being tested with many other malignancies for its ability to change patient management. This article provides an overview of the current status of FDG-PET and presents the challenges of moving toward routine use.

DOI: 10.1016/j.suc.2010.10.012
Version: za2963e q8za1 q8zbc q8zc8 q8zdc q8ze1 q8zfc q8zg7
View PDF

Similar articles you may find interesting…

  1. Diseases of the female pelvis: advances in imaging evaluation.
    Alice C Brandão and Anelise Oliveira Silva

    Magn Reson Imaging Clin N Am 21(2):447-69 (2013) PMID 23642562

    Magnetic resonance (MR) imaging has been widely accepted as a powerful imaging modality for the evaluation of the pelvis because of its intrinsic superior soft tissue contrast compared with that of computed tomography. In certain cases, however, the morphologic study provided by MR i...
    Buy PDF
  2. An ordered-subsets proximal preconditioned gradient algorithm for edge-preserving PET image reconstruction.
    Abolfazl Mehranian, Arman Rahmim, and Habib Zaidi

    Med Phys 40(5):052503 (2013) PMID 23635293

    The proposed PPG-OS algorithm shows an improved convergence rate with the ability of incorporating additional boundary information in regularized PET image reconstruction....
    Buy PDF
  3. Visualizing Hepatic Copper Release in Long-Evans Cinnamon Rats Using Single-Photon Emission Computed Tomography.
    Eric M Yezdimer, Tomohiro Umemoto, and Ikuo Tooyama

    Appl Biochem Biotechnol (2013) PMID 23645415

    Our evaluation methodology consisted of administering the indium-labeled agent to both LEC and genetically healthy Long-Evans (LE) cohorts via a tail vein injection and following the pharmacokinetics with single-photon emission computed tomography (SPECT) over the course of an hour. The animals were...
    Buy PDF